Valuation: Sun Pharmaceutical Industries Ltd.

Market Cap 4,530B 47.31B 41.5B 38.31B 35.4B 67.11B 68.45B 461B 179B 2,217B 178B 174B 7,696B P/E 2027 *
34.6x
P/E 2028 * 29.3x
Enterprise Value 4,243B 44.31B 38.87B 35.88B 33.16B 62.85B 64.11B 431B 168B 2,076B 166B 163B 7,208B EV / Sales 2027 *
6.49x
EV / Sales 2028 * 5.72x
Free-Float
44.39%
Yield 2027 *
0.84%
Yield 2028 * 0.94%
1 day+2.67%
1 week+3.62%
Current month+4.09%
1 month+8.98%
3 months+12.91%
6 months+12.07%
Current year+12.73%
1 week 1,871.6
Extreme 1871.6
1,952
1 month 1,771
Extreme 1771
1,952
Current year 1,583.7
Extreme 1583.7
1,952
1 year 1,548
Extreme 1548
1,952
3 years 1,031.1
Extreme 1031.1
1,960.35
5 years 666.4
Extreme 666.4
1,960.35
10 years 312
Extreme 312
1,960.35
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer 59 01/09/2025
Director of Finance/CFO 58 01/07/2025
Director TitleAgeSince
Chairman 70 -
Director/Board Member 59 01/09/2025
Director/Board Member 73 25/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.67%+3.62%+16.13%+85.52% 47.31B
-0.81%-4.53%+65.57%+113.67% 36.04B
+0.66%-1.01%-3.38%+41.76% 12.08B
+0.96%+5.38%+18.45%+99.28% 11.96B
+0.57%+1.95%+34.36%+123.93% 9.05B
+0.50%-0.33%+17.76%+44.55% 6.92B
-1.61%+1.96%+54.90%-2.70% 7.19B
+1.96%+3.24%+24.65%+241.55% 6.55B
-7.00%+5.26%-20.00%+10.09% 5.9B
+0.88%-1.13%+25.90%+135.15% 4.28B
Average -0.12%+1.32%+23.43%+89.28% 14.73B
Weighted average by Cap. +0.60%+1.99%+29.12%+91.43%

Financials

2027 *2028 *
Net sales 654B 6.83B 5.99B 5.53B 5.11B 9.69B 9.88B 66.5B 25.84B 320B 25.65B 25.09B 1,111B 729B 7.62B 6.68B 6.17B 5.7B 10.8B 11.02B 74.15B 28.81B 357B 28.6B 27.98B 1,239B
Net income 132B 1.38B 1.21B 1.12B 1.03B 1.96B 2B 13.43B 5.22B 64.64B 5.18B 5.07B 224B 156B 1.63B 1.43B 1.32B 1.22B 2.31B 2.36B 15.86B 6.16B 76.35B 6.12B 5.98B 265B
Net Debt -287B -3B -2.63B -2.43B -2.25B -4.26B -4.34B -29.22B -11.35B -141B -11.27B -11.02B -488B -359B -3.75B -3.29B -3.03B -2.8B -5.31B -5.42B -36.47B -14.17B -176B -14.07B -13.76B -609B
Logo Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Employees
47,000
Date Price Change Volume
09/07/26 1,938.70 +2.67% 4,446,201
08/07/26 ₹1,888.20 -0.80% 2,785,926
07/07/26 ₹1,903.40 -0.49% 2,060,613
06/07/26 ₹1,912.80 +0.42% 1,213,635
03/07/26 ₹1,904.80 +1.81% 2,168,491
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
1,888.20INR
Average target price
2,055.00INR
Spread / Average Target
+8.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SUNPHARMA Stock